-
effectivehealthcare.ahrq.gov/products/continuous-outcomes-correlation/research
November 19, 2012 - Empirical Assessment of Within-Arm Correlation Imputation in Trials of Continuous Outcomes
Research Report November 19, 2012 Web Version [NLM Site] Download Main Document PDF 4.4 MB
People using assistive technology may not be able to fully access information in these files. For additional assistance, p…
-
effectivehealthcare.ahrq.gov/products/bayesian-mixed-treatment/research
January 31, 2013 - Findings of Bayesian Mixed Treatment Comparison Meta-Analyses: Comparison and Exploration Using Real-World Trial Data and Simulation
Research Report January 31, 2013 Web Version [NLM Site] Download Main Document PDF 2.4 MB
People using assistive technology may not be able to fully access information in …
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/ptsd-3-draft-report.pdf
January 12, 2022 - • For all 427 RCTs, we abstracted data to calculate standardized effect sizes for continuous
PTSD … as follows:
Reported and Evidence-based Practice Center (EPC) calculated; Reported, EPC unable to
calculate … ; NR, EPC calculated; or NR, EPC unable to calculate. … final report to summarize the number and proportion of studies for which we could extract and/or
calculate … NR, EPC
calculated
NR, EPC unable to
calculate
Psychotherapy
Studies To be added to final To
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
October 17, 2012 - For studies amenable to pooling with meta-analyses, we will calculate pooled mean differences, risk … When we are unable to pool studies, we will calculate and display the individual mean differences, risk … Since many trials do not provide enough
information to calculate a confidence interval
around the difference … For studies amenable to pooling with
meta-analyses, we will calculate
pooled mean differences, risk … When we are unable to pool studies,
we will calculate and display the
individual mean differences,
-
effectivehealthcare.ahrq.gov/products/migraine-prevention/research
June 11, 2013 - Current Page Topic Timeline Jun. 2, 2011 Topic Initiated Nov. 3, 2011 Research Protocol Jun. 3, 2013 Topic Overview Jun. 11, 2013 Systematic Review Aug. 8, 2013 Disposition of Comments Report Migraine in Children: Preventive Pharmacologic Treatments
Systematic Review Archived June 11, 2013 Web Version [NLM Site] D…
-
effectivehealthcare.ahrq.gov/webform/products/pcor-depression/submit-comments
April 01, 2021 - Home »
Webform »
Products »
Pcor Depression »
Submit Comments
Open for comment:
Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression
Research Report Draft April 1, 2021 Download Main Document PDF 1.8 MB
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_executive.pdf
September 01, 2009 - difference
Insufficient Data are inadequate to calculate outcomes or are not reported.
5
Key Question … difference
Insufficient Data are inadequate to calculate outcomes or are not reported.
7
Key Question
-
effectivehealthcare.ahrq.gov/products/gestational-diabetes-screening-diagnosis/research-protocol
December 16, 2011 - If necessary, we will approximate means by medians and use 95% confidence intervals to calculate approximate … We will calculate p-values when they are not reported. 26
For KQ1, we will construct 2x2 tables and … calculate sensitivity, specificity, positive and negative predictive values, reliability and yield of … For continuous variables, we will calculate mean differences for individual studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
December 16, 2011 - If necessary, we will approximate means by medians and use 95%
confidence intervals to calculate approximate … We will calculate p-values
when they are not reported.
26
For KQ1, we will construct 2x2 tables … and calculate sensitivity, specificity, positive and
negative predictive values, reliability and yield … For continuous variables, we will calculate mean differences for individual studies.
-
effectivehealthcare.ahrq.gov/products/glaucoma-screening/research-protocol
November 16, 2010 - Measures of treatment effect
We will calculate summary risk ratios or odds ratios as appropriate for … For Key Question 3, we will calculate diagnostic odds ratios. … We will verify normality of continuous outcomes and calculate mean differences; standardized mean differences
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
November 16, 2010 - Measures of treatment effect
We will calculate summary risk ratios or odds ratios as appropriate for … For Key
Question 3, we will calculate diagnostic odds ratios. … We will verify normality of continuous outcomes
and calculate mean differences; standardized mean differences
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
February 11, 2013 - We did not use any data from unreported
studies (e.g., Kramer and Landolt, 2011) to
calculate our effect
-
effectivehealthcare.ahrq.gov/products/cardiology-health-outcomes/research
July 28, 2010 - We used Kaplan-Meier methods to calculate unadjusted 30-day and 1-year mortality rates.
-
effectivehealthcare.ahrq.gov/products/preterm-birth-terbutaline-pump/research-protocol
August 05, 2010 - As appropriate for each outcome outlined in KQ1 through KQ4, we will calculate the following summary … confidence intervals:
For continuous outcomes (e.g., gestational age at delivery, birthweight) we will calculate … , neonatal brochopulmonary dysplasia, retinopathy of prematurity, maternal pulmonary edema) we will calculate … For the time to event outcome (i.e. time to delivery) we will calculate the pooled hazard ratio. … doses, dislodgement and overdoses) we will pool reported incidence data using a random effects model to calculate
-
effectivehealthcare.ahrq.gov/products/c-difficile-update/research-protocol
December 23, 2014 - available, we will use statistical differences to assess efficacy and comparative effectiveness and calculate … Since two primary endpoints will be used, sensitivity and specificity, we will calculate 99 percent confidence … Depending on the heterogeneity of prevalence of CDI in diagnostic accuracy studies, we may also calculate … Further, when possible, we will calculate positive and negative likelihood ratios that allow clinicians … We will calculate risk ratios (RR) and absolute risk differences (RD) with the corresponding 95 percent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
December 23, 2014 - available, we will use statistical differences to
assess efficacy and comparative effectiveness and calculate … Since two primary endpoints
will be used, sensitivity and specificity, we will calculate 99 percent … Depending on the heterogeneity of prevalence of CDI in diagnostic accuracy
studies, we may also calculate … Further, when possible, we will calculate positive and negative
likelihood ratios that allow clinicians … We will calculate risk ratios (RR)
and absolute risk differences (RD) with the corresponding 95 percent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
October 18, 2010 - As appropriate for each outcome outlined in KQ1 through KQ4, we will calculate
the following summary … confidence intervals:
• For continuous outcomes (e.g., gestational age at delivery, birthweight) we will
calculate … neonatal brochopulmonary dysplasia,
retinopathy of prematurity, maternal pulmonary edema) we will calculate … • For the time to event outcome (i.e. time to delivery) we will calculate the
pooled hazard ratio … , dislodgement and overdoses) we will
pool reported incidence data using a random effects model to calculate
-
effectivehealthcare.ahrq.gov/products/quantitative-synthesis-expanded-methods/methods
March 13, 2013 - Similar to relative risk, investigators should calculate NNT/NNH based on combined hazard ratio or rate … For time to event data and count data, investigators should also calculate NNT/NNH while incorporating
-
effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - Slide 1
Research Triangle Institute
RTI International is a trade name of Research Triangle Institute. www.rti.org
The Use of Conjoint Analysis to Elicit
Patient Preferences in Selecting
Treatment Endpoints
F. Reed Johnson, PhD
Distinguished Fellow and Principal Economist
Research Triangle Institute
I…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_research-2011.pdf
January 01, 2011 - Engaging Stakeholders to Identify and Prioritize Topics for Future Research: Recommended activities and reporting practices
1
Engaging Stakeholders to Identify and Prioritize Topics for Future Research: Recommended
activities and reporting practices
This table presents a series of recommended activities for resea…